In fact, previous studies have indicated a role for lipophilic statins such as Simvastatin and Lovastatin as inhibitors of farnesyl transferase activity and RAS/RHO activity and to have the capacity to inhibit the growth of breast cancer cells in vitro[34]. Here, RHO is linked to breast carcinoma.